Gastrointestinal complications of systemic sclerosis

World Journal of Gastroenterology

Volumn 19, Issue 41, 2013, Pages 7062-7068

  Tian, Xin Ping ^a   Zhang, Xuan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Diagnosis; Endoscopy; Gastrointestinal tract; Manometry; Systemic sclerosis; Treatment

Indexed keywords

BISACODYL; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DOMPERIDONE; ERYTHROMYCIN; LACTULOSE; MACROGOL; MACROLIDE; METOCLOPRAMIDE; METRONIDAZOLE; NEOSTIGMINE; OCTREOTIDE; PROBIOTIC AGENT; PRUCALOPRIDE; TEGASEROD; URSODEOXYCHOLIC ACID; COLLAGEN;

ABDOMINAL DISTENSION; ANUS SPHINCTER; BACTERIAL OVERGROWTH; BARRETT ESOPHAGUS; BEDTIME DOSAGE; BLOATING; CALCINOSIS; CAUTERIZATION; DRUG DOSE INCREASE; DYSPEPSIA; DYSPHAGIA; ENDOSCOPY; FECES INCONTINENCE; FIBROMUSCULAR DYSPLASIA; FIBROSING ALVEOLITIS; GASTRIC DYSMOTILITY; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HIGH FIBER DIET; HUMAN; IMMUNOPATHOLOGY; INTESTINAL DYSMOTILITY; INTESTINE PSEUDOOBSTRUCTION; KIDNEY INJURY; LACTOBACILLUS; MALABSORPTION; MUSCLE ATROPHY; NAUSEA AND VOMITING; NEUROPATHY; PERIODONTAL DISEASE; PNEUMATOSIS INTESTINALIS; PRIMARY BILIARY CIRRHOSIS; REFLUX ESOPHAGITIS; REVIEW; SCLEROTHERAPY; SENNA; STEATORRHEA; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH FUNDOPLICATION; STOMACH PARESIS; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VASCULAR DISEASE; BILIARY TRACT DISEASE; CLINICAL FEATURE; ESOPHAGUS; GASTROINTESTINAL DISEASE; LIVER DISEASE; MALNUTRITION; MANOMETRY; MOUTH CAVITY; PATHOGENESIS; SMALL INTESTINE DISEASE; VOMITING;

DIAGNOSIS; ENDOSCOPY; GASTROINTESTINAL TRACT; MANOMETRY; SYSTEMIC SCLEROSIS; TREATMENT;

EARLY DIAGNOSIS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL DISEASES; HUMANS; MANOMETRY; PREDICTIVE VALUE OF TESTS; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 84887529198     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i41.7062     Document Type: Review

References (36)

1. Tiev KP, Cabane J. Digestive tract involvement in systemic sclerosis. Autoimmun Rev 2011; 11: 68-73 [PMID: 20601200]
2. Forbes A, Marie I. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48 Suppl 3: iii36-iii39 [PMID: 19487222 DOI: 10.1093/rheumatology/ken485]
3. Thoua NM, Bunce C, Brough G, Forbes A, Emmanuel AV, Denton CP. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology (Oxford) 2010; 49: 1770-1775 [PMID: 20530510 DOI: 10.1093/rheumatology/keq147]
4. Schmeiser T, Saar P, Jin D, Noethe M, Müller A, Soydan N, Hardt PD, Jaeger C, Distler O, Roeb E, Bretzel RG, Müller-Ladner U. Profile of gastrointestinal involvement in patients with systemic sclerosis. Rheumatol Int 2012; 32: 2471-2478 [PMID: 21769490 DOI: 10.1007/s00296-011-1988-6]
5. Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 2012; 14: 22-29 [PMID: 22105546 DOI: 10.1007/s11926-011-0217-3.]
6. Singh J, Mehendiratta V, Del Galdo F, Jimenez SA, Cohen S, DiMarino AJ, Rattan S. Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1206-G1213 [PMID: 19779020 DOI: 10.1152/ajpgi.00286.2009]
7. Manetti M, Neumann E, Milia AF, Tarner IH, Bechi P, Matucci-Cerinic M, Ibba-Manneschi L, Müller-Ladner U. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 2007; 56: 3442-3447 [PMID: 17907149]
8. Zuber-Jerger I, Müller A, Kullmann F, Gelbmann CM, Endlicher E, Müller-Ladner U, Fleck M. Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign. Rheumatology (Oxford) 2010; 49: 368-372 [PMID: 20008473 DOI: 10.1093/rheumatology/kep381]
9. Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994; 94: 761-770 [PMID: 8040331]
10. Nishimagi E, Tochimoto A, Kawaguchi Y, Satoh T, Kuwana M, Takagi K, Ichida H, Kanno T, Soejima M, Baba S, Kamatani N, Hara M. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007; 34: 2050-2055 [PMID: 17924608]
11. Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-2444 [PMID: 11083266]
12. Savas N, Dagli U, Ertugrul E, Kuran S, Sahin B. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations. Dig Dis Sci 2007; 52: 3081-3086 [PMID: 17393310]
13. Thonhofer R, Siegel C, Trummer M, Graninger W. Early endoscopy in systemic sclerosis without gastrointestinal symptoms. Rheumatol Int 2012; 32: 165-168 [PMID: 20711592 DOI: 10.1007/s00296-010-1595-y]
14. Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 2006; 36: 173-181 [PMID: 17045629]
15. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006; 23: 691-712 [PMID: 16556171]
16. Wipff J, Allanore Y, Soussi F, Terris B, Abitbol V, Raymond J, Chaussade S, Kahan A. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005; 52: 2882-2888 [PMID: 16142744]
17. Marie I, Levesque H, Ducrotté P, Denis P, Hellot MF, Benichou J, Cailleux N, Courtois H. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001; 96: 77-83 [PMID: 11197291]
18. Elkayam O, Oumanski M, Yaron M, Caspi D. Watermelon stomach following and preceding systemic sclerosis. Semin Arthritis Rheum 2000; 30: 127-131 [PMID: 11071584]
19. Fynne L, Worsøe J, Gregersen T, Schlageter V, Laurberg S, Krogh K. Gastrointestinal transit in patients with systemic sclerosis. Scand J Gastroenterol 2011; 46: 1187-1193 [PMID: 21815862 DOI: 10.3109/00365521.2011.603158]
20. Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, Savarino E, Indiveri F, Savarino V, Ghio M. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008; 103: 1257-1262 [PMID: 18422815 DOI: 10.1111/ j.1572-0241.2007.01758.x]
21. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002; 123: 1144-1150 [PMID: 12360477]
22. Marie I, Ducrotté P, Denis P, Menard JF, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) 2009; 48: 1314-1319 [PMID: 19696066 DOI: 10.1093/rheumatology/kep226]
23. Sagara A, Kitagawa K, Furuichi K, Kitajima S, Toyama T, Okumura T, Hara A, Sakai Y, Kaneko S, Wada T. Three cases of pneumatosis intestinalis presenting in autoimmune diseases. Mod Rheumatol 2012; 22: 610-615 [PMID: 22068684 DOI: 10.1007/s10165-011-0551-3]
24. Vischio J, Matlyuk-Urman Z, Lakshminarayanan S. Benign spontaneous pneumoperitoneum in systemic sclerosis. J Clin Rheumatol 2010; 16: 379-381 [PMID: 21085017 DOI: 10.1097/ RHU.0b013e3181ffeb49]
25. Thoua NM, Schizas A, Forbes A, Denton CP, Emmanuel AV. Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology (Oxford) 2011; 50: 1596-1602 [PMID: 21504990 DOI: 10.1093/rheumatology/ker153]
26. Heyt GJ, Oh MK, Alemzadeh N, Rivera S, Jimenez SA, Rattan S, Cohen S, Dimarino AJ. Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an associa-tion with fecal incontinence. Dig Dis Sci 2004; 49: 1040-1045 [PMID: 15309898]
27. Thoua NM, Abdel-Halim M, Forbes A, Denton CP, Emmanuel AV. Fecal incontinence in systemic sclerosis is secondary to neuropathy. Am J Gastroenterol 2012; 107: 597-603 [PMID: 22085820 DOI: 10.1038/ajg.2011.399]
28. Malandrini A, Selvi E, Villanova M, Berti G, Sabadini L, Salvadori C, Gambelli S, De Stefano R, Vernillo R, Marcolongo R, Guazzi G. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases. J Rheumatol 2000; 27: 1203-1206 [PMID: 10813288]
29. Akimoto S, Ishikawa O, Muro Y, Takagi H, Tamura T, Miyachi Y. Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J Dermatol 1999; 26: 18-22 [PMID: 10063207]
30. Imura-Kumada S, Hasegawa M, Matsushita T, Hamaguchi Y, Encabo S, Shums Z, Norman GL, Takehara K, Fujimoto M. High prevalence of primary biliary cirrhosis and diseaseassociated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol 2012; 22: 892-898 [PMID: 22327744 DOI: 10.1007/s10165-012-0607-z]
31. Norman GL, Bialek A, Encabo S, Butkiewicz B, Wiechowska-Kozlowska A, Brzosko M, Shums Z, Milkiewicz P. Is prevalence of PBC underestimated in patients with systemic sclerosis? Dig Liver Dis 2009; 41: 762-764 [PMID: 19357001 DOI: 10.1016/j.dld.2009.01.014]
32. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Semin Arthritis Rheum 2005; 34: 689-702 [PMID: 15692963]
33. Baron M, Bernier P, Côté LF, Delegge MH, Falovitch G, Friedman G, Gornitsky M, Hoffer J, Hudson M, Khanna D, Paterson WG, Schafer D, Toskes PP, Wykes L. Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol 2010; 28: S42-S46 [PMID: 20576213]
34. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996; 8: 569-575 [PMID: 9018461]
35. Frech TM, Khanna D, Maranian P, Frech EJ, Sawitzke AD, Murtaugh MA. Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention. Clin Exp Rheumatol 2011; 29: S22-S25 [PMID: 21586214]
36. Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients. J Clin Rheumatol 2007; 13: 119-123 [PMID: 17551375]